feed,title,long_url,short_url
Benzinga,Sanofi's Amcenestrant Combo Therapy Shows ORR of 34% In Breast Cancer Patients,https://benzinga.com/general/biotech/21/05/21221959/sanofis-amcenestrant-combo-therapy-shows-orr-of-34-in-breast-cancer-patients,https://j.mp/3f6Uiu9
Benzinga,Oncolytics Pelareorep/Pembrolizumab Combo Therapy Shows Anti-Cancer Activity In Pancreatic Cancer,https://benzinga.com/general/biotech/21/05/21221684/oncolytics-pelareoreppembrolizumab-combo-therapy-shows-anti-cancer-activity-in-pancreatic-cancer,https://j.mp/3hFrYAu
